In vitro effects of an imidazole antifungal, prochloraz, on spectral and catalytic properties of microsomal cytochromes P-450

References

• Black S. D., Coon M. J. Comparative structures of cytochromes P-450. Cytochrome P-450: Structure, Metabolism and Biochemistry, P.R. Ortiz de Montellano. Plenum Press, New York 1986; 161–216
   Google Scholar
• Burke M. D., Mayer R. T. Ethoxyresorufin. Direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metabolism and Disposition 1974; 2: 583–588
   PubMed Web of Science ®Google Scholar
• Conney A. H. Induction of microsomal cytochrome P-450 enzymes. Life Sciences 1986; 39: 2493–2518
   PubMed Web of Science ®Google Scholar
• Delaforgf M., Koop D. R., Coon M. J. Role of isosafrole as complexing agent and inducer of P-450LM4 in rabbit liver microsomes. Biochemical and Biophysical Research Communications 1982; 108: 59–65
   PubMedGoogle Scholar
• Delaforge M., Jaouen M., Mansuy M. Dual effects of macrolide antibiotics on rat liver cytochrome P-450. Induction and formation of metabolite complexes: a structure activity relationship. Biochemical Pharmacology 1983; 32: 2309–2315
   PubMed Web of Science ®Google Scholar
• Delaforge M. D., Ioannides C., Parke D. V. Ligand-complex formation between cytochromes P-450 and P-448 and methylenedioxyphenyl compounds. Xenobiotica 1985; 15: 333–342
   PubMed Web of Science ®Google Scholar
• Gillette J., Sasame H., Stipp B. Mechanisms of inhibition of drug metabolic reactions. Drug Metabolism and Disposition 1973; 1: 164–175
   PubMed Web of Science ®Google Scholar
• Gonzales F. J. The molecular biology of cytochrome P450s. Pharmacological Reviews 1989; 40: 243–288
   Web of Science ®Google Scholar
• Henry M. J., Sisler H. D. Effects of sterol biosynthesis-inhibiting (SBI) fungicides on cytochrome P-450 oxygenations in fungi. Pesticide Biochemistry and Physiology 1984; 22: 262–275
   Web of Science ®Google Scholar
• Higashi Y., Omura M., Suzuki K., Inano H., Oshima H. Ketoconazole as a possible universal inhibitor of cytochrome P-450 dependent enzymes: its mode of action. Endocrinology Japan 1987; 34: 105–115
   PubMedGoogle Scholar
• Kan P. B., Hirst M. A., Feldman D. Inhibition of steroidogenic cytochrome P-450 enzymes in rat testis by ketoconazole and related imidazole antifungal drugs. Journal of Steroid Biochemistry 1985; 23: 1023–1029
   PubMedGoogle Scholar
• Leibman K. C., Ortiz E. New potent modifiers of liver microsomal drug metabolism: 1-arylmidazoles. Drug Metabolism and Disposition 1973; 1: 775–779
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Ioannides C., Parke D. V. Molecular dimensions of the substrate binding site of cytochrome P-448. Biochemical Pharmacology 1986; 35: 2179–2185
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Roseborough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Lubet R. A., Mayer R. T., Camerom J. W., Nims R. W., Burke M. D., Wolff R., Guengerich F. P. Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in rat. Archives of Biochemistry and Biophysics 1985; 238: 43–48
   PubMed Web of Science ®Google Scholar
• Meredith C. G., Maldonado A. L., Speeg K. V. The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro. Drug Metabolism and Disposition 1985; 13: 156–162
   PubMed Web of Science ®Google Scholar
• Morita K., Ono T., Shimakawa H. Inhibitory effects of ketocanazole and miconazole on cytochrome P-450 mediated oxidative metabolism of testosterone and xenobiotics in mouse hepatic microsomes: comparative study with cimetidine. Journal of Pharmacobiology and Dynamics 1988; 11: 106–114
   PubMedGoogle Scholar
• Nagai K., Miyamori I., Ikeda M., Koshida H., Takeda R., Suhara K., Katagiri M. Effect of ketoconazole (an imidazole antimycotic agent) and other inhibitors of steroidogenesis on cytochrome P-450 catalyzed reactions. Journal of Steroid Biochemistry 1986; 24: 321–323
   PubMedGoogle Scholar
• Nash T. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochemical Journal 1953; 55: 416–421
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Gonzales F. J. Cytochrome P-450 gene expression and regulation. Trends in Pharmaceutical Sciences 1985; 6: 160–164
   Web of Science ®Google Scholar
• Nebert D. W., Adesnik M., Coon M. J., Estabrook R. W., Gonzales F. J., Guengerich F. P., Gunsalus I. C., Johnson E. F., Kemper B., Levin W., Phillips I. R., Sato R., Waterman M. R. The P450 gene superfamily recommended nomenclature. DNA 1987; 6: 1–11
   PubMedGoogle Scholar
• Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes. Journal of Biological Chemistry 1964; 239: 2370–2378
   PubMed Web of Science ®Google Scholar
• Philips A. H., Langdon R. G. Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation characterisation and kinetic studies. Journal of Biological Chemistry 1962; 237: 2652–2660
   PubMed Web of Science ®Google Scholar
• Phillipson C. E., Ioannides C., Delaforge M., Parke D. V. Studies on the substrate binding sites of liver microsomal cytochrome P-448. Biochemical Journal 1982; 207: 51–56
   PubMed Web of Science ®Google Scholar
• Rodriguez A. D., Lewis D. F. W., Ioannides C., Parke D. V. Spectral and kinetic studies of the interaction of imidazole anti-fungal agents with microsomal cytochromes P-450. Xenobiotica 1987; 17: 1315–1327
   PubMedGoogle Scholar
• Rogerson T. D., Wilkinson C. F., Hetnarski K. Steric factors in the inhibitory interaction of imidazole with microsomal enzymes. Biochemical Pharmacology 1977; 26: 1039–1042
   PubMed Web of Science ®Google Scholar
• Schenkman J. B., Remmer H., Estabrook R. W. Spectral studies of drug interaction with hepatic microsomal cytochrome. Molecular Pharmacology 1967; 3: 113–123
   PubMed Web of Science ®Google Scholar
• Schenkman J. B. Studies on the nature of the type I and type II spectral changes in liver microsomes. Biochemistry 1970; 9: 2081–2091
   PubMed Web of Science ®Google Scholar
• Schenkman J. B., Cinti D. L., Moldeus P. V., Orrenius S. Newer aspects of substrate binding to cytochrome P-450. Drug Metabolism and Disposition 1973; 1: 11–120
   Google Scholar
• Sheets J. J., Mason J. I. Ketoconazole: a potent inhibitor of cytochrome P-450-dependent drug metabolism in rat liver. Drug Metabolism and Disposition 1984; 12: 603–606
   PubMed Web of Science ®Google Scholar
• Sheets J. J., Mason J. I., Wise C. A., Estabrook R. W. Inhibition of rat liver microsomal cytochrome P-450 steroid hydroxylase reactions by imidazole antimycotic agents. Biochemical Pharmacology 1986; 35: 487–491
   PubMed Web of Science ®Google Scholar
• Vanden-Bossche H., Lauwers W., Willemsens G., Mahichal P., Cools W. The molecular basis for the antifungal activities of N-substituted azole derivatives. Focus on R51211. The Mode of Action of Antifungal Agents, A. Trinci, J. Ryley. Symposium of the British Mycological Society, Cambridge University Press, Cambridge 1984; 321–341
   Google Scholar
• Whitlock J. P. The regulation of cytochrome P-450 gene expression. Annual Review of Pharmacology and Toxicology 1986; 26: 333–369
   PubMed Web of Science ®Google Scholar
• Wrighton S. A., Maurel P., Schuetz E. G., Watkins P. B., Young B., Guzelian P. S. Identification of the cytochrome P-450 induced by macrolide antibiotics in rat liver as the glucocorticoid responsive cytochrome P-450p. Biochemistry 1985; 24: 2171–2178
   PubMed Web of Science ®Google Scholar